AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11752035 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibition (ACEi) with enalapril 5 mg once daily
Number of subjects: 19
Study 11752035 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined volume reduction with dialysis and ACEi
Number of subjects: 19
Study 9721002 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g x day(‐1), given in 4 x 6‐g doses of 5 g creatine monohydrate and 1 g glucose for 5 days)
Number of subjects: 16
Study 9721002 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 16
Study 9721002 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 16
Study 8620951 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 25 micrograms
Number of subjects: 23
Study 8620951 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms
Number of subjects: 23
Study 8620951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2506966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 254
Study 2506966 — intervention group
Group type: COMPARATOR
Intervention: Topical steroids and mydriatics (Control)
Number of subjects: 254
Study 4244871 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified ampicillin (Penbritin)
Number of subjects: 0
Study 4244871 — intervention group
Group type: COMPARATOR
Intervention: Unpurified ampicillin (Penbritin)
Number of subjects: 0
Study 31596612 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Ureteroscopy Lithotripsy (FURL)
Number of subjects: 220
Study 31596612 — intervention group
Group type: COMPARATOR
Intervention: Miniaturized Percutaneous Nephrolithotomy (MPCNL)
Number of subjects: 220
Study 28258434 — intervention group
Group type: EXPERIMENTAL
Intervention: USG-guided corticosteroid injection (40 mg/2 mL methylprednisolone acetate)
Number of subjects: 40
Study 28258434 — intervention group
Group type: COMPARATOR
Intervention: Blinded corticosteroid injection (40 mg/2 mL methylprednisolone acetate)
Number of subjects: 40
Study 26364080 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-induced collapse before vitrification
Number of subjects: 270
Study 26364080 — intervention group
Group type: COMPARATOR
Intervention: Vitrification without collapsing (Control)
Number of subjects: 270
Study 23123790 — intervention group
Group type: EXPERIMENTAL
Intervention: low volume, low intensity exercise
Number of subjects: 320
Study 23123790 — intervention group
Group type: EXPERIMENTAL
Intervention: high volume, low intensity exercise
Number of subjects: 320
Study 23123790 — intervention group
Group type: EXPERIMENTAL
Intervention: high volume, high intensity exercise
Number of subjects: 320
Study 23123790 — intervention group
Group type: COMPARATOR
Intervention: no-exercise control
Number of subjects: 320
Study 21544005 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ribavirin (RBV) at a moderate dose (8.33 mg/kg/dose q 8 hours on day 1, 5 mg/kg/dose q 8 hours on days 2-10)
Number of subjects: 19
Study 21544005 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ribavirin (RBV) at an escalated dose (33 mg/kg on day 1, then 16 mg/kg/dose q 6 hours for 4 days, and 8 mg/kg/dose q 8 hours for 3 days)
Number of subjects: 19
Study 21544005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18297416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus gabapentin
Number of subjects: 40
Study 18297416 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine alone
Number of subjects: 40
Study 16594804 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail users and nonusers discussing e-mail and traditional communication methods
Number of subjects: 68
Study 16594804 — intervention group
Group type: COMPARATOR
Intervention: Traditional media
Number of subjects: 68
Study 15754838 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive HUT (P group)
Number of subjects: 176
Study 15754838 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 176
Study 15754838 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged asystole (PAS group)
Number of subjects: 176
Study 11385119 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic lead exposure
Number of subjects: 23
Study 11385119 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 23
Study 9061991 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 0
Study 9061991 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapeutic touch)
Number of subjects: 0
Study 7953415 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 30
Study 7953415 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 30
Study 2887134 — intervention group
Group type: EXPERIMENTAL
Intervention: Orogastric lavage
Number of subjects: 10
Study 2887134 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipecac-induced emesis
Number of subjects: 10
Study 2887134 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal
Number of subjects: 10
Study 2887134 — intervention group
Group type: COMPARATOR
Intervention: Control ingestion
Number of subjects: 10
Study 31944487 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose tDCS (2.5 mA for 30 min)
Number of subjects: 130
Study 31944487 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose tDCS (0.034 mA for 30 min)
Number of subjects: 130
Study 30139638 — intervention group
Group type: EXPERIMENTAL
Intervention: IBI-10090 (5 μL injection of 517 μg)
Number of subjects: 181
Study 30139638 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1.0% (1 drop 4 times daily for 3 weeks)
Number of subjects: 181
Study 30139638 — intervention group
Group type: EXPERIMENTAL
Intervention: IBI-10090
Number of subjects: 181
Study 30139638 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 181
Study 26990899 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-enabled research informed consent
Number of subjects: 131
Study 26990899 — intervention group
Group type: COMPARATOR
Intervention: Standard face-to-face (F2F) research informed consent
Number of subjects: 131
Study 25721132 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based interactive exercise training (twice a week for 4 weeks)
Number of subjects: 39
Study 23553157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (1.3 g/d)
Number of subjects: 67
Study 23553157 — intervention group
Group type: COMPARATOR
Intervention: High-sodium diet (3.8 g/d)
Number of subjects: 67
Study 23553157 — intervention group
Group type: EXPERIMENTAL
Intervention: Black girls
Number of subjects: 67
Study 23553157 — intervention group
Group type: COMPARATOR
Intervention: White girls
Number of subjects: 67
Study 20957858 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac MRI
Number of subjects: 0
Study 18226761 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally relevant messages, community member referral networks, and adjustment to community realities
Number of subjects: 0
Study 16321668 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day
Number of subjects: 45
Study 16321668 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/day
Number of subjects: 45
Study 14600695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin adhesive
Number of subjects: 34
Study 14600695 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide cement
Number of subjects: 34
Study 10914620 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT decision aids
Number of subjects: 156
Study 10914620 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider discussion about menopause
Number of subjects: 156
Study 8991493 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 x 25 mg clomipramine hydrochloride tablets (Noristan Ltd.)
Number of subjects: 0
Study 8991493 — intervention group
Group type: COMPARATOR
Intervention: Anafranil 2 x 25 mg tablets (clomipramine HCl; Ciba‐Geigy (Pty) Ltd.)
Number of subjects: 0
Study 8991493 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 x 10 mg clomipramine hydrochloride tablets (Noristan Ltd.)
Number of subjects: 0
Study 8991493 — intervention group
Group type: COMPARATOR
Intervention: Anafranil 5 x 10 mg tablets (clomipramine HCl; Ciba‐Geigy (Pty) Ltd.)
Number of subjects: 0
Study 1389190 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental with infusion of sufentanil 0.1 microgram/kg/hr
Number of subjects: 30
Study 1389190 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental with infusion of fentanyl 1 microgram/kg/hr
Number of subjects: 30
Study 1389190 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of 0.25% to 2% isoflurane
Number of subjects: 30
Study 3999630 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs (including diuretics)
Number of subjects: 0
Study 3999630 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0
Study 3999630 — intervention group
Group type: COMPARATOR
Intervention: Untreated hypertensive patients
Number of subjects: 0
Study 31733809 — intervention group
Group type: EXPERIMENTAL
Intervention: Perseus A500 (redesigned)
Number of subjects: 16
Study 31733809 — intervention group
Group type: COMPARATOR
Intervention: GE Aespire 7900 (conventional)
Number of subjects: 16
Study 30473540 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide injection: 0.6‐1.2 mg/day, 12 weeks, n=52
Number of subjects: 127
Study 30473540 — intervention group
Group type: COMPARATOR
Intervention: Metformin (oral metformin: 1000‐1500 mg/day, 12 weeks, n=75)
Number of subjects: 127
Study 27125172 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning program
Number of subjects: 44
Study 27125172 — intervention group
Group type: COMPARATOR
Intervention: traditional classroom lecture
Number of subjects: 44
Study 24081874 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-ILI-QoL
Number of subjects: 125
Study 24081874 — intervention group
Group type: COMPARATOR
Intervention: SF-12v2 Acute Form
Number of subjects: 125
Study 22449295 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 1370
Study 22449295 — intervention group
Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 1370
Study 20400552 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy
Number of subjects: 127
Study 20400552 — intervention group
Group type: COMPARATOR
Intervention: Intensive comparison therapy
Number of subjects: 127
Study 20400552 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 127
Study 18533791 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic sponge based on polylactic‐polyglycolic acid technology (FIS)
Number of subjects: 8
Study 18533791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral (BPBM)
Number of subjects: 8
Study 18533791 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural coral derivative (COR)
Number of subjects: 8
Study 18533791 — intervention group
Group type: COMPARATOR
Intervention: Non-grafted control
Number of subjects: 8
Study 15990986 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (OASIS 1)
Number of subjects: 349
Study 15990986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone/metronidazole (OASIS II)
Number of subjects: 349
Study 15990986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertapenem
Number of subjects: 349
Study 12393986 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with or without radiotherapy (26 epirubicin, 19 epirubicin + ifosfamide)
Number of subjects: 88
Study 12393986 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with or without radiotherapy
Number of subjects: 88
Study 12393986 — intervention group
Group type: COMPARATOR
Intervention: Surgery with or without radiotherapy
Number of subjects: 88
Study 10654875 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg/day bisoprolol
Number of subjects: 11
Study 10654875 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/day bisoprolol
Number of subjects: 11
Study 10654875 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects receiving 5.0 mg/day bisoprolol
Number of subjects: 11
Study 7751412 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide 1.25 mg/day
Number of subjects: 222
Study 7751412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 2190040 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (120 mg)
Number of subjects: 17
Study 2190040 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (30 mg)
Number of subjects: 17
Study 628896 — intervention group
Group type: EXPERIMENTAL
Intervention: External pneumatic compression (EPC) of the calves
Number of subjects: 95
Study 628896 — intervention group
Group type: COMPARATOR
Intervention: No specific form of prophylaxis (Control)
Number of subjects: 95
Study 31807856 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae CNCM I-3856
Number of subjects: 100
Study 31807856 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae CNCM I-3856 (IBS-D subgroup)
Number of subjects: 100
Study 31807856 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae CNCM I-3856 (IBS-C subgroup)
Number of subjects: 100
Study 31807856 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae CNCM I-3856 (IBS-M subgroup)
Number of subjects: 100
Study 31807856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30472215 — intervention group
Group type: EXPERIMENTAL
Intervention: CST-AET (Coping Skills Training for Adherence to Endocrine Therapy)
Number of subjects: 400
Study 30472215 — intervention group
Group type: COMPARATOR
Intervention: General health education intervention (comparison condition)
Number of subjects: 400
Study 30472215 — intervention group
Group type: EXPERIMENTAL
Intervention: CST-AET
Number of subjects: 400
Study 27787700 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.4 mg) and Indomethacin (50 mg)
Number of subjects: 23
Study 27787700 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin and Placebo
Number of subjects: 23
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Men not on ART prior to surgery
Number of subjects: 223
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative weeks 1-3
Number of subjects: 223
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative week 6
Number of subjects: 223
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative week 12
Number of subjects: 223
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with HIV plasma VL > 50,000 copies/ml
Number of subjects: 223
Study 25919012 — intervention group
Group type: COMPARATOR
Intervention: Men with healed MC wounds
Number of subjects: 223
Study 25919012 — intervention group
Group type: COMPARATOR
Intervention: Men on ART with undetectable plasma VL
Number of subjects: 223
Study 25919012 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with ART-induced undetectable plasma VL
Number of subjects: 223
Study 23371002 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-endoscopic surgery
Number of subjects: 192
Study 23371002 — intervention group
Group type: COMPARATOR
Intervention: Microsurgery
Number of subjects: 192
Study 21250973 — intervention group
Group type: EXPERIMENTAL
Intervention: Revaccination with non-live vaccines after chemotherapy, starting as early as 3 months post-chemotherapy.
Number of subjects: 0
Study 19283649 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise; details on dosage and duration not available
Number of subjects: 0
Study 19283649 — intervention group
Group type: COMPARATOR
Intervention: Control group; details not specified
Number of subjects: 0
Study 17583186 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release niacin (1000 mg)
Number of subjects: 167
Study 17583186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 10965639 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy treatment for BED
Number of subjects: 162
Study 8989743 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 10
Study 8989743 — intervention group
Group type: COMPARATOR
Intervention: Nondialysis day
Number of subjects: 10
Study 8989743 — intervention group
Group type: EXPERIMENTAL
Intervention: First hour of hemodialysis
Number of subjects: 10
Study 8989743 — intervention group
Group type: EXPERIMENTAL
Intervention: Second hour of hemodialysis
Number of subjects: 10
Study 8989743 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdialysis period
Number of subjects: 10
Study 1291593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone (4 g of vaginal cream containing 2.5% natural progesterone)
Number of subjects: 80
Study 1291593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 1291593 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone
Number of subjects: 80
Study 6712445 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ultrasound (US)
Number of subjects: 10
Study 6712445 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared radiation
Number of subjects: 10
Study 6712445 — intervention group
Group type: COMPARATOR
Intervention: Pulsed ultrasound (US)
Number of subjects: 10
Study 6712445 — intervention group
Group type: COMPARATOR
Intervention: Placebo ultrasound (US)
Number of subjects: 10
Study 30863474 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl matrix
Number of subjects: 108
Study 30863474 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 108
Study 29843644 — intervention group
Group type: EXPERIMENTAL
Intervention: COACH intervention (integrated care model with primary care provider and Aging Worker)
Number of subjects: 2400
Study 29843644 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care‐as‐Usual (eCAU)
Number of subjects: 2400
Study 27741123 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait therapy (RAGT) combined with rehabilitation therapy (RT)
Number of subjects: 56
Study 27741123 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation therapy (RT) alone
Number of subjects: 56
Study 24820311 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservatives
Number of subjects: 0
Study 24820311 — intervention group
Group type: COMPARATOR
Intervention: Liberals
Number of subjects: 0
Study 22682044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene liners (5.0 Mrad gamma-irradiation and heat treated)
Number of subjects: 230
Study 22682044 — intervention group
Group type: COMPARATOR
Intervention: Non-cross-linked polyethylene liners
Number of subjects: 230
Study 22682044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene liners
Number of subjects: 230
Study 20976738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic (STN) stimulation
Number of subjects: 45
Study 18514630 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid (AA) treatment, 70.6 kcal/day (8 g of essential AAs) given at 10:00 am and 5:00 pm
Number of subjects: 41
Study 18514630 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid (AA) treatment
Number of subjects: 41
Study 15838723 — intervention group
Group type: EXPERIMENTAL
Intervention: brimonidine 0.2%
Number of subjects: 40
Study 15838723 — intervention group
Group type: COMPARATOR
Intervention: apraclonidine 1%
Number of subjects: 40
Study 12417888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine 180 mg
Number of subjects: 21
Study 12417888 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 21
Study 12417888 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine 8 mg
Number of subjects: 21
Study 10516513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonometry with disposable latex cap (Group B)
Number of subjects: 80
Study 10516513 — intervention group
Group type: COMPARATOR
Intervention: Tonometry without disposable latex cap (Group A)
Number of subjects: 80
Study 10516513 — intervention group
Group type: COMPARATOR
Intervention: Tonometry without latex cap in patients with IOP >/=20 mm Hg (Group A1)
Number of subjects: 80
Study 10516513 — intervention group
Group type: COMPARATOR
Intervention: Tonometry without latex cap in patients with IOP <20 mm Hg (Group A2)
Number of subjects: 80
Study 10516513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonometry with latex cap in patients with IOP >/=20 mm Hg (Group B1)
Number of subjects: 80
Study 10516513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonometry with latex cap in patients with IOP <20 mm Hg (Group B2)
Number of subjects: 80
Study 7793203 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia (n = 12)
Number of subjects: 21
Study 7793203 — intervention group
Group type: COMPARATOR
Intervention: Enflurane anaesthesia (n = 9)
Number of subjects: 21
Study 1790403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) 75 mg/day
Number of subjects: 84
Study 1790403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 31624422 — intervention group
Group type: EXPERIMENTAL
Intervention: Hf‐WBV (higher frequency, 5 times per week)
Number of subjects: 60
Study 31624422 — intervention group
Group type: EXPERIMENTAL
Intervention: Lf‐WBV (lower frequency, 3 times per week)
Number of subjects: 60
Study 31624422 — intervention group
Group type: COMPARATOR
Intervention: CG (control group, no training)
Number of subjects: 60
Study 30431567 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaft method to place biological mesh
Number of subjects: 60
Study 30431567 — intervention group
Group type: COMPARATOR
Intervention: Traditional tiling method
Number of subjects: 60
Study 27208320 — intervention group
Group type: EXPERIMENTAL
Intervention: GLIPULIN (exenatide dosing before meals)
Number of subjects: 102
Study 27208320 — intervention group
Group type: COMPARATOR
Intervention: BBI (rapid-acting insulin analogs)
Number of subjects: 102
Study 27208320 — intervention group
Group type: EXPERIMENTAL
Intervention: GLIPULIN
Number of subjects: 102
Study 27208320 — intervention group
Group type: COMPARATOR
Intervention: BBI
Number of subjects: 102
Study 25282565 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1000 IU/day)
Number of subjects: 107
Study 25282565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107